Statement from Michael Sapienza, CEO of the Colon Cancer Alliance, on FDA Approval of VARUBI Intravenous Administration
October 26, 2017 (WASHINGTON)–VARUBI, a highly anticipated treatment for colorectal patients who suffer from delayed chemotherapy-induced nausea, has been approved by the Food and Drug Administration for delivery via one-time intravenous administration. This new way to administer VARUBI provides healthcare providers with flexibility to treat patients in a more individualized manner.
VARUBI addresses delayed nausea that can arrive 24 to 120 hours after the start of chemotherapy. If nausea is not managed aggressively, it can lead to weight loss, dehydration, and hospitalization. Quality-of-life issues are incredibly important for patients and families dealing with colorectal cancer and chemotherapy. The approval of VARUBI is good step forward in addresses some of these concerns.
For more information about VARUBI, please access:
https://globenewswire.com/news-release/2017/10/25/1153687/0/en/TESARO-Announces-U-S-FDA-Approval-of-VARUBI-IV-for-Delayed-Nausea-and-Vomiting-Associated-With-Cancer-Chemotherapy.html
Top resources
Never Too Young Taskforce Tackles Growing Crisis as Cases of the Deadliest Cancer Continue to Rise in People Under 50
The Colorectal Cancer Alliance's Never Too Young Taskforce of CRC patients, survivors, caregivers, and experts drives awareness and advocacy, while Project Cure CRC is accelerating research toward better treatments to help end this disease.
Alliance releases 2025 annual report
Our 2025 annual report documents a year of progress in the mission to end colorectal cancer.
Senators Markey, Klobuchar, Rep. Carson Introduce Legislation to Address the Surge of Cancer Among Young Adults
Senator Edward J. Markey (D-Mass.), top Democrat on the Health, Education, Labor, and Pensions (HELP) Subcommittee on Primary Health and Retirement Security, along with Senator Amy Klobuchar (D-Minn.) and Congressman André Carson (IN-07), introduced the Asal Sayas National Strategy on Young Adult Cancers Act to establish a national strategy to tackle the growing epidemic of cancer among adults under age 50.